Cargando…

Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene

BACKGROUND: Tumor formation is a complex process which involves constitutive activation of oncogenes and suppression of tumor suppressor genes. Receptor EphA2 and its ligand ephrin-A1 form an important cell communication system with its functional role in cell-cell interaction and tumor growth. Loss...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sukka-Ganesh, Bhagyalaxmi, Mohammed, Kamal A, Kaye, Frederic, Goldberg, Eugene P, Nasreen, Najmunnisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488573/ https://www.ncbi.nlm.nih.gov/pubmed/22824143 http://dx.doi.org/10.1186/1471-2407-12-309

Ejemplares similares

Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer
por: Lee, Hung-Yen, et al.
Publicado: (2013)

Cdx2 Regulates Intestinal EphrinB1 through the Notch Pathway
por: Zhu, Yalun, et al.
Publicado: (2021)

Heme Oxygenase-1 Deficiency Diminishes Methicillin-Resistant Staphylococcus aureus Clearance Due to Reduced TLR9 Expression in Pleural Mesothelial Cells
por: Gahlot, Satindra, et al.
Publicado: (2017)

Overlapping functions of Cdx1, Cdx2, and Cdx4 in the development of the amphibian Xenopus tropicalis
por: Faas, Laura, et al.
Publicado: (2009)

Transduced caudal‐type homeobox (CDX) 2/CDX1 can induce growth inhibition on CDX‐deficient gastric cancer by rapid intestinal differentiation
por: Nakayama, Chiemi, et al.
Publicado: (2018)

Cdx1 and Cdx2 Exhibit Transcriptional Specificity in the Intestine
por: Grainger, Stephanie, et al.
Publicado: (2013)

ALK (D5F3) CDx: an immunohistochemistry assay to identify ALK-positive NSCLC patients
por: Uruga, Hironori, et al.
Publicado: (2018)

Induction of Suppressor Cells and Increased Tumor Growth following Chronic Psychosocial Stress in Male Mice
por: Schmidt, Dominic, et al.
Publicado: (2016)

Eph Receptors and Ephrin Ligands: Important Players in Angiogenesis and Tumor Angiogenesis
por: Mosch, Birgit, et al.
Publicado: (2010)

The Eph/Ephrin system in primary bone tumor and bone cancer pain
por: Wang, Lujuan, et al.
Publicado: (2023)

CDX1 and CDX2 Expression in Intestinal Metaplasia, Dysplasia and Gastric Cancer
por: Kang, Jung Mook, et al.
Publicado: (2011)

miR-657 Targets SRCIN1 via the Slug Pathway to Promote NSCLC Tumor Growth and EMT Induction
por: Zhang, Yingqian, et al.
Publicado: (2022)

DRAM1 plays a tumor suppressor role in NSCLC cells by promoting lysosomal degradation of EGFR
por: Geng, Ji, et al.
Publicado: (2020)

Tumor suppressor genes are reactivated by miR-26A1 via enhancer reprogramming in NSCLC
por: Li, Hongling, et al.
Publicado: (2022)

AMPK promotes induction of the tumor suppressor FLCN through activation of TFEB independently of mTOR
por: Collodet, Caterina, et al.
Publicado: (2019)

miR-103 Functions as a Tumor Suppressor by Directly Targeting Programmed Cell Death 10 in NSCLC
por: Yang, Dong, et al.
Publicado: (2018)

Reactivation of the homeotic tumor suppressor gene CDX2 by 5-aza-2′-deoxycytidine-induced demethylation inhibits cell proliferation and induces caspase-independent apoptosis in gastric cancer cells
por: ZHANG, JIAN-FENG, et al.
Publicado: (2013)

Extracellular Superoxide Dismutase: Growth Promoter or Tumor Suppressor?
por: Laukkanen, Mikko O.
Publicado: (2016)

Relationships Between the Expressions of CDX1 and CDX2 mRNA and Clinicopathologic Features in Colorectal Cancers
por: Kim, Gwang Ha, et al.
Publicado: (2005)

Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision‐Making for Patients with Advanced Solid Tumors
por: Takeda, Masayuki, et al.
Publicado: (2021)

Clinical and analytical validation of FoundationOne(®)CDx, a comprehensive genomic profiling assay for solid tumors
por: Milbury, Coren A., et al.
Publicado: (2022)

Rapid tumor induction in zebrafish by TALEN-mediated somatic inactivation of the retinoblastoma1 tumor suppressor rb1
por: Solin, Staci L., et al.
Publicado: (2015)

Recent advances in SHH medulloblastoma progression: tumor suppressor mechanisms and the tumor microenvironment
por: Tamayo-Orrego, Lukas, et al.
Publicado: (2019)

TUSC1, a Putative Tumor Suppressor Gene, Reduces Tumor Cell Growth In Vitro and Tumor Growth In Vivo
por: Shan, Zhihong, et al.
Publicado: (2013)

At the double for tumor suppressor
por: Sonawane, Mahendra
Publicado: (2016)

Growth cone response to ephrin gradients produced by microfluidic networks
por: Lang, Susanne, et al.
Publicado: (2007)

NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors
por: Yang, Michelle X., et al.
Publicado: (2018)

Ephrin Receptors (Ephs) Expression in Thymic Epithelial Tumors: Prognostic Implications and Future Therapeutic Approaches
por: Masaoutis, Christos, et al.
Publicado: (2021)

EphB4 and ephrinB2 act in opposition in the head and neck tumor microenvironment
por: Bhatia, Shilpa, et al.
Publicado: (2022)

Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications
por: Papadakos, Stavros P., et al.
Publicado: (2023)

Resveratrol induces the growth inhibition of CDX-deficient gastric cancer cells using CDX2 and RUNX3 via the β-catenin/TCF4 signaling pathway
por: Liu, Hui, et al.
Publicado: (2023)

Focus on Nintedanib in NSCLC and Other Tumors
por: Manzo, Anna, et al.
Publicado: (2016)

Dimethyl Sulfoxide Promotes the Multiple Functions of the Tumor Suppressor HLJ1 through Activator Protein-1 Activation in NSCLC Cells
por: Wang, Chi-Chung, et al.
Publicado: (2012)

Tumor Milieu Controlled by RB Tumor Suppressor
por: Kitajima, Shunsuke, et al.
Publicado: (2020)

Tumor suppressor ARF regulates tissue microenvironment and tumor growth through modulation of macrophage polarization
por: Jiménez-García, Lidia, et al.
Publicado: (2016)

Phytochemical Compositions of Immature Wheat Bran, and Its Antioxidant Capacity, Cell Growth Inhibition, and Apoptosis Induction through Tumor Suppressor Gene
por: Kim, Mi Jeong, et al.
Publicado: (2016)

The transcription factor Cdx2 regulates inflammasome activity through expression of the NLRP3 suppressor TRIM31 to maintain intestinal homeostasis
por: Jahan, Sanzida, et al.
Publicado: (2022)

The Clinical Impact of the EPH/Ephrin System in Cancer: Unwinding the Thread
por: Pergaris, Alexandros, et al.
Publicado: (2021)

Immunohistochemical Expression of CDX2 in Gastric Carcinoma
por: Sardar, Ahmed Avan, et al.
Publicado: (2022)

Expression of CDX2 in metastatic prostate cancer
por: Guerrieri, C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ohtrppemooab4c1dev1r2pnkq5